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India is the country with the largest number of tuberculosis (TB) cases, 
contributing 20% of the global burden of infection (1) and 2 million cases annually 
(2). However, few if any studies have examined the epidemiology of TB in the 
Northern state of Himachal Pradesh. 
This study is a retrospective review of medical records of all tuberculosis 
patients (N=1086) seen at the two hospitals in Manali, District Kullu, Himachal 
Pradesh, India between 2008 and 2011. 
 
The analysis determined that being younger, female, living in a town, and/or a 
patient at Mission Hospital, were factors significantly associated with having 
extrapulmonary versus pulmonary tuberculosis (EPTB). Being older was associated 
with an increased likelihood of previous/complex treatment compared to new 
patients. Being female, from a town, and/or older was associated with receiving a 
non-standard regimen. Finally, patients who were previously treated/complex were 
significantly more likely to receive a non-standard regimen than new patients. 
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This work is dedicated to the people of Manali and District Kullu, India 
who continue to suffer unnecessarily from the burden of tuberculosis. 
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Chapter 1:  Introduction 
 
 
I.  Background 
 
Tuberculosis, HIV/AIDS, and Malaria are considered the world’s three most 
devastating infectious diseases (Hotez, et al., 2006).  The disease is estimated to have 
resulted in 1.7 million deaths in 2009 (WHO, 2010) and 34.2 million disability adjusted 
life years (DALY’s) in 2004 (WHO, 2004).  The infection which is caused by 
Mycobacterium tuberculosis bacilli disproportionately affects countries in the developing 
world – particularly in South-East Asia and Africa (WHO, 2010).  The global prevalence 
of tuberculosis in 2010 was 164 cases per 100,000 population, with an annual incidence 




Due to its population of 1.2 billion people and the relatively high prevalence of the 
disease in the region, India is the country with the largest number of tuberculosis cases of 
any country in the world.   It contributes 20%  of  the global burden of  tuberculosis 




Given the high prevalence of tuberculosis in the Indian sub-continent, the 
distribution of the disease has been studied in detail in certain major urban centers and at 
the national level (SEARO/WHO, 2009).  However, few if any studies have examined the 
distribution and risk factors for tuberculosis in the Northern state of Himachal Pradesh. 
Differences in socio-economic status, access to care, and topography of the region may 











1. Overall Goal: 
 
This research project seeks to contribute to an improved knowledge of tuberculosis 
infection among patients seen by two of the major healthcare providers in District Kullu, 
Himachal Pradesh – Lady Willingdon (Mission) Hospital and the government’s Civil 
Hospital, by analyzing variations in the demographic composition of disease by hospital, 
site of infection, category of treatment, and type of treatment regimen received.  The 
independent variables to be studied include age, gender, and residence (town vs. village), 
as well as the hospital where treatment was received and the treatment category the 
patient was prescribed.  Efforts will also be made to identify further research questions 
and areas where additional study is needed.   The research questions broadly fall into two 
categories: distribution of TB infection by demographic characteristics and characteristics 




This research will contribute to the body of knowledge on the characteristic 
presentation of tuberculosis within the population of District Kullu.  In order for effective 
public health systems to be in place and targeted control efforts to be utilized, baseline 
data on the distribution and risk factors for tuberculosis needs to be understood within the 









Q1.   Are the people seen at the government hospital different than those seen at the 
private hospital with regard to the demographic characteristics of: age, gender, or 
residence in village/town? (Descriptive) 
Null Hypothesis: There will be no difference between the people seen at the 
 
government and private hospital with regard to the demographic characteristics of 
age, gender, and/or residence. 
Alternative Hypothesis: There will be one or  more differences between the 
 
people  seen  at  the  government  and  private  hospital  with  regard  to  the 
demographic characteristics of age, gender, and/or residence. 
Variables to Include: 
 





Q2. Is there an association between the demographic characteristics (age, gender, 
village/town), and site of TB infection (pulmonary, extrapulmonary-EPTB)? (Analytic) 
Null Hypothesis:  There will be no association between the demographic 
characteristics (age, gender, residence, and/or hospital) and the site of tuberculosis 
infection, adjusting for potential demographic characteristic confounders. 
Alternative Hypothesis: There will be one or more associations between the 
demographic characteristics (age, gender, residence, and/or hospital) and the site 
of tuberculosis infection, adjusting for each of the other demographic 




Variables to Include: 
 
● Independent Variables: Age, Gender, Residence, Hospital 
 





Q3.  Is there an association between demographic characteristics and presenting with 
disease after treatment (DAT) – shown as classification in Category II/IV as opposed to a 
first instance of TB shown by classification in Category I/III? (Analytic) (see pg. 12  for 
more detail) 
Null Hypothesis:  There will be no  association  between  the  demographic 
 
characteristics  (age,  gender,  residence,  and/or  hospital)  and  presenting  with 
disease after treatment (DAT – Cat. I/III vs. Cat. II/IV), adjusting for potential 
demographic characteristic confounders. 
Alternative Hypothesis:   There will be one or more associations between the 
 
Demographic characteristics (age, gender, residence, and/or hospital) and 
presenting with disease after treatment (DAT – Cat. I/III (New) Cat. II/IV  





Variables to Include: 
 
● Independent Variables: Age, Gender, Residence, Hospital 
 




Q4. Is there an association between demographic variables and type of treatment 
regimen received? 
Null Hypothesis:  There will be no association between the demographic 
 
characteristics (age, gender, residence, and/or hospital) and type of treatment 
regimen  received  (standard  vs.  non-standard),  adjusting  for  potential 
demographic characteristic confounders. 
Alternative Hypothesis:   There will be one or more associations between the 
 
demographic characteristics (age, gender, residence, and/or hospital) and type of 
treatment regimen received (standard vs. non-standard), adjusting for potential 




Variables to Include: 
 
● Independent Variables: Age, Gender, Residence, Hospital 
 





Q5.  Is there an association between category of treatment and type of treatment regimen 
received (standard vs. non-standard), adjusting for all other covariates (demographic 
variables)? 
Null Hypothesis: There will be no association between category of treatment (N, 
 
PTC)  and type of treatment regimen received (standard vs. non-standard), 
adjusting for potential demographic characteristic confounders? 
Alternative Hypothesis: There  will  be  an  association  between  category  of 
 









Variables to Include: 
 
● Independent Variables: Category of Treatment (N, PTC) 
 





The majority of the initial chi-squared tests have demonstrated statistically significant 
differences between the observed and hypothesized proportions of the independent 
variables (age, gender, residence, hospital), and dependent variables (treatment category, 
TB type, and regimen), and this led to    further analysis.  Univariate and multivariate- 
adjusted logistic regression will be performed to determine the associations between the 









1.  Tuberculosis Treatment System in India: 
 
Tuberculosis  is  treated  in  India  by  a  complex  system  of  public  and  private 
providers.  All citizens of India are supposed to be able to access tuberculosis case 
detection and treatment services through the Government of India’s Revised National 
Tuberculosis Control Program (RNTCP). The RNTCP principally implements a version 
of the World Health Organization’s STOP TB recommended directly observed treatment 
short-course program (DOTS) (RNTCP, 2011).  This program is intended to standardize 
case detection, treatment regimens, and improve program implementation.   Treatment is 
provided in pre-formed patient-wise boxes based on patient weight through a system of 
more than 300,000 DOTS centres/providers (SEARO/WHO, 2009).   However, many 
Indians prefer to seek treatment from private providers.   While the RNTCP maintains 
strong records and thus is able to provide a relatively high quality of information, there is 
generally a dearth of data and information from the providers in the private sector. 
Furthermore, lack of infrastructure makes data collection difficult as patient records are 




2.  District Kullu, State of Himachal Pradesh: 
 
Located in the far north of the country, much of the state of Himachal Pradesh lies 
in the Himalayan mountain range, with 90% of the population living in rural areas 
(Census of India 2011: Administrative Atlas of India, 2011).   The mountainous terrain 




treatment for many months or years, as is the case with tuberculosis.  A survey by the 
National Rural Health Mission found that only 8.4% of the villages had Primary Health 
Centres (PHCs) and 17.4% had private clinics.  It was found that there was a severe 




Himachal Pradesh’s status as a relatively advanced state means that little attention 
has been focused upon it with regard to diseases linked to poverty, including tuberculosis. 
Also, the state has an extremely low rate of HIV infection.  HIV infection is an important 
risk factor for tuberculosis and has resulted in much higher incidence rates of TB in 
regions endemic with both HIV and TB. Because of its very low levels of HIV infection, 
this area serves as an important reference for understanding risk factors and distribution 
of tuberculosis in the absence of high rates of HIV. Analysis of risk factors for 
tuberculosis in the absence of high rates of HIV  is critical because these factors are 
significantly altered by co-infection.   Further, there remains a significant burden of 
tuberculosis that clearly impacts the functioning of society.  Tuberculosis is identified by 
local medical practitioners as the greatest health problem affecting the region (personal 




Kullu is one of 12 districts in the state of Himachal Pradesh.  The town of Manali 
is the home of two hospitals – one government (Civil) hospital, and the other a mission 
hospital (LWH).   Due to the lack of quality health care available within much of the 
district and the state as a whole, many residents choose to seek care from one of the two 




437,474 – of which 91% live in rural areas (India, 2011).    The district sex ratio is 950 
females per 1000 males (India, 2011).   As the major hub of care for the region, the two 
hospitals in Manali can provide much needed information on the distribution of 





3.  Mortality, Incidence and Prevalence of TB in India: 
 
The South-East Asian Regional Office of the World Health Organization 
(SEARO/WHO) estimates that 331, 268 deaths in India in 2006 were due to tuberculosis 
(SEARO/WHO, 2009).  In 2008, the incidence rate of tuberculosis in India was estimated 
to be 168 cases per 100,000 population and the prevalence rate 283 cases per 100,000 
population for all forms of tuberculosis (SEARO/WHO, 2009).  The rate of new 
infection does not appear to have decreased over the past two decades, despite the 




While efforts are being made to improve the quality of information and the 
estimates available regarding the prevalence and incidence of infection in India, even the 
current estimates contain uncertainty and few if any estimates are available at the district 
or state level.  There are currently not routine notification data systems in place for 
measuring disease incidence and there is a considerable need to continue to improve the 
use of population-based surveys and to work towards the use of routine case notifications 











4.1 - Age: 
 
In India, the majority of cases are found in the 15-54 year old age group (SEARO/WHO, 
 
2009).  However, in a study conducted in Iran, the majority of cases were among patients 
aged 55 and above (Khazaei, 2005).   Another investigation in Taipei found a 
predominance of cases among patients aged 25-34 and above 65 years of age (Wang 
2002). In contrast, a study conducted in Mexico found a linear trend associated with age 
(OR= 1.02 per year) (Bustamante-Montes et al., 2000).  In a study of risk factors among 
household contacts of tuberculosis patients in The Gambia, age was associated with risk 
of infection.  Risk of infection was highest among ages 25-34 and 35-49 year olds, (OR = 
8.55, 95% CI: 6.31-11.58 and OR=8.35, 95% CI: 6.05-11.53, respectively) when 
compared to the age group 0-14 years (Lienhardt et al., 2003). 
While there is some variation in the literature, much of the data supports the claim that 
tuberculosis most heavily effects the most productive groups in society, largely those 




4.1.1 - Age and Site of TB Infection 
 
Age  is  considered  a  risk  factor  for  extrapulmonary  tuberculosis  (EPTB)  in  some 
scenarios.  For example, a study conducted in France found that risk factors for EPTB, 
including age, varied according to area of birth.  For patients born in Sub-Saharan Africa, 
age was associated with EPTB, however, this was not the case for individuals born in 




Sub-Saharan Africa. The risk of EPTB in sub-saharan Africa was highest among 
individuals aged 40-59 years (OR=1.63, 99% CI=1.14-2.32) when compared to the 
reference group of 0-24 years (Cailhole et al., 2005).   This study suggests that it may be 
important to consider interaction effects that may modify the association of age with 
tuberculosis outcomes.   In contrast, a study from Taiwan found that the incidence of 
EPTB vs. pulmonary TB decreased significantly as age increased by decades, again 
compared to the referent age group 0-24 years (OR = 0.85, 95% CI = 0.75-0.95) (Lin et 
al., 2009).   This evidence suggests that there are inconsistent findings on associations 





4.1.2 - Age and Disease after Treatment 
 
Little data exists on any associations between age and category of treatment.  Those 
patients with a very young age are less likely to be Category II, because they are unlikely 
to have been previously treated.  Similarly, one would expect the likelihood of being 
Category II versus I or III to increase with age, as the opportunity for previous disease 
and treatment grows over time.    A study among children in Northern India found that 
among a total of 459 patients started on therapy, 323 patients were in Category I, 120 in 
Category III, 12 in Category II and 4 in Category IV.  This means that 443 of the 459 
pediatric patients (96.5%) were new patients and only 16 (3.5%) were patients who had 
previously been treated or were complex (Kabra, Lodha, & Seth, 2004).    Therefore, 





Disease after treatment is a method of classification that is being used as a proxy for 
previous treatment resulting in treatment failure, default, or relapse, or for multi-drug 
resistant (MDR) TB cases.   Literature on previously treated and MDR cases were 
reviewed for associations with age.   A study of 11 countries by the WHO found that 
patients in all age groups above age 15 were significantly more likely to have resistant 
strains of tuberculosis than those aged 0-14 years; particularly age groups 35-44 years 
and 55-64 years (OR= 3.0, 95% CI: 1.7-5.3; OR=2.7, 95% CI: 1.5-3.8, respectively). 
Likelihood of resistance however was lowest in the age group over 65 years, after the 
youngest group, which was used as the reference (OR= 1.9, 95%CI: 1.0-3.4) (Espinal 
2001).  In a study of treatment non-adherence, which is a risk factor for treatment failure, 
relapse, and MDR (Category II and Category IV patients), older and younger age groups 
were identified as high-risk for non-adherence (Munro et al. 2007).   Again, there is 
conflicting  evidence  in  the  literature  about  which  age  groups  are  most  likely  to 
experience disease after treatment.  Children are least at risk, and the risk also appears to 
be low for older adults.  Those in middle-age are at the highest risk of MDR (Category 
IV), however younger and older groups are more likely to be non-adherent, making them 




4.1.3 - Age and Receipt of Treatment Regimen 
 
To  the  best  of  my  knowledge,  little  research  has  explicitly  examined  associations 
between age and receipt of a standard versus non-standard regimen.   What has been 
studied is receipt of DOTS versus non-DOTS, which could serve as a proxy measure 




found that there was no significant difference in age among patients who received DOTS 
versus non-DOTS treatment (Balasubramanian et al., 2000).   Studies have found that 
previous treatment is one of the most significant risk factors for MDR-TB.   Estimates 
from the WHO indicate that patients who have previously been treated are 2.5 times more 
likely to develop MDR-TB then those who are new patients (OR= 2.5, 95%CI: 2.1-3.0) 
(Espinal 2001).  Given the increasing complexity of the regimen for patients who have 
been previously treated or are suspected to be MDR, one would anticipate that these 
patients would be more likely to receive a non-standard regimen.  This would suggest 
that patients in the age ranges of 35-44 and 55-64 years (Espinal 2001) would be the most 
likely to receive a non-standard regimen, as they are the most likely to have been 
previously treated and/or be MDR.  It is believed that non-standard regimens lead to drug 
resistance and that this is more common in previously-treated patients and those that have 
received longer courses of therapy.  Espinal et al. (2001) found that drug resistance was 
significantly associated with an overall prior treatment period of greater than or equal to 6 
months(OR=7.6, 95%CI: 2.6-22.4), and that the risk increased with longer treatments. 
Evidence from their study supports the hypothesis that inappropriate and/or interrupted 
treatment resulted in higher rates of drug resistance among patients receiving longer 
courses of therapy previously (Espinal 2001).  This suggests that there may also be an 
association between age and the receipt of a non-standard regimen, in the patients who 




4.2 - Gender: 
 
Indian men are disproportionately affected by TB at the country-level with a male-female 
ratio of newly detected cases of 2:1 (SEARO/WHO, 2009). In most countries, according 
to case notification figures, more men than women are diagnosed with tuberculosis, 
although this could be the result of sociological differences in access to care or biological 
differences, or a combination of both (Thorson and Garcia-Moreno, 2009). Epidemiologic 
data shows that there are differences between men and women in terms of “prevalence of 
infection, rate of progression from infection to disease, incidence of clinical disease, and 
mortality due to tuberculosis” (Diwan & Thorson, 1999). “The higher proportion of 
male cases consistently reported by TB programmes may accurately reflect a greater 
prevalence among men, or it may be an artifact of persisting geographic, socioeconomic, 
cultural, and health service-related barriers that disproportionately affect timely diagnosis 




A 2005 study from Iran, however, found that women resulted in 58.1% of the cases, 
although the proportion changed with older age (Khazaei 2005).  According to reports on 
the global epidemiology of tuberculosis, the disease primarily affects men, particularly 
after adolescence (Dye, 2009; Holmes, Hausler, and Nunn, 1998).   Recent analyses 
however,  suggest  that  women  of  reproductive  age  have  a  higher  propensity  for 
developing TB disease after infection than men of the same age (Holmes, Hausler, and 
Nunn, 1998).  Studies from the 1960’s in Bangalore and Chingleput, India found the 
prevalence of tuberculosis was similar in males and females until the age of 14, after 




(Gothi et al., 1974 and Baily et al., 1980 in Homes, Hausler, and Nunn, 1998).  One study 
trying to determine whether gender differences in tuberculosis prevalence were due to 
biological differences or sociological factors found that the female/male “sex ratio of 
prevalent cases was similar or lower than that in notified cases, suggesting that F/M 
differences in notified cases may be largely due to epidemiological differences in 
biological  risk  by  sex  rather  than  to  differential  access  to  health  care  by  gender.” 
However, the authors suggest that these rates of notification may be distorted in parts of 
Asia (e.g. India) because so many patients are seen by private practitioners who rarely 
report case notifications accurately.  Thus it is difficult to determine if gender differences 
in tuberculosis infection and treatment are the result of biological differences or socio- 
cultural factors (Borgdorff, Nagelkerke, Dye, and Nunn, 2000).  In a study of risk factors 
among household contacts of tuberculosis patients in Africa, sex was determined to be a 
risk factor for infection.   Women were less likely to be infected than men with 
tuberculosis (OR = 0.84, 95% CI:  0.73-0.97) (Lienhardt et al., 2003). Finally, a study 
comparing prevalence of tuberculosis among men and women in the National Family 
Health Survey of India rounds 2 and 3, found that the gender gap increased (more men 
were infected than women in both years, but the difference increased in the 3rd  round), 
 
and that this difference was three times larger in rural areas then in urban areas (Sharma, 
Kumar, and Singh, 2010).  A study of gender and TB in Bangladesh found that the 
Female/Male (F/M) ratio of individuals started on TB treatment was 0.35.   They also 
found that this association declined steeply with age.   The ratio for under age 15 was 
2.20 and decreased to 0.08 among patients over age 65 (Begum et al. 2001).   Given 




the relationship between gender and tuberculosis may be modified by age.   This may be 
in part due to the fact that younger women with children are likely to have more frequent 
contact with outpatient services because of their children (Begum et al. 2001). 
Together, the literature indicates that men in India are more likely to be diagnosed with 





4.2.1 - Gender and Type of Tuberculosis (P/EP) 
 
Type of tuberculosis and site of infection are thought to be differentially affected by 
gender.   A study of risk factors for extrapulmonary tuberculosis (EPTB) found that 
women were nearly twice as likely to develop EPTB as men (OR = 1.98, 95% CI: 1.25- 
3.13) (Yang et al. 2004).  A study in the U.S. from 1993-2006 found that compared to 
pulmonary tuberculosis, cases of extrapulmonary TB were 1.7 times more likely to be 
female than male (OR = 1.7, 95% CI: 1.7-1.8) (Peto et al., 2009).   A study from Taiwan 
also found that being female was an independent risk factor for EPTB when examined by 
multivariate regression (OR=1.69, 95%CI: 1.02–2.80) (Lin et al., 2009).    The literature 
on site of infection and gender seems to consistently find that women are more likely to 




4.2.2 - Gender and Treatment Category 
 
Little  information  has  been  found  on  associations  between  gender  and  treatment 
category..   This may be due in part to the fact that treatment categories is an unusual 




and smear negative patients (Category I or III) that were women were each 31-32% 
according to a study conducted by the RNTCP (RNTCP 2004).  Research on risk factors 
for  MDR-TB found  that women were slightly less likely than men to  have a drug 
resistant strain (Category IV), however the association did not reach the level of 
significance (OR=0.93, 95%CI: 0.83-1.0) (Espinal 2001).  Treatment category is directly 
related to patient adherence to tuberculosis treatment.  Patients who fail to adhere to their 
treatment are much more likely to become Category II or Category IV cases (previously 
treated, MDR, complex) (Munro et al, 2007).  Thus, differences in treatment adherence 
by gender may help to explain possible differences in treatment category by gender. 
Females were perceived as being more motivated to adhere to their treatment, but they 
are also more likely to have their access to treatment be mitigated by the requirement that 
they have permission from their father or husband and/or be accompanied to attain 
treatment (Munro et al. 2007).  Two studies in this meta-analysis also found that female 
patients who were, or wanted to become, pregnant were less likely to adhere to their 
treatment because they perceived the medication to be harmful (Munro et al. 2007). 
Research from sites on multiple continents, including India, found that women are more 
likely to drop out during the course of diagnosis, while men are less likely to successfully 
complete treatment one started (Weiss et al. 2006).  Either of these factors could lead to 
higher proportions of Category II/IV patients.  Therefore, the evidence remains 





4.2.3 - Gender and Treatment Regimen 
 
Researchers in India found that there was no significant difference in gender among 
patients who received DOTS versus non-DOTS treatment (Balasubramanian et al., 2000). 
Using DOTS vs. non-DOTS as a proxy for treatment regimen (DOTS = standard 
regimen), the study in India did find that women were less likely to receive DOTS, 
although this association was only marginally significant (p=.06).  This suggests that 
women may be slightly more likely to receive a non-standard regimen than men.  Women 
commonly cited social stigma as the reason for not receiving DOTS (Balasubramanian et 
al., 2000).   A study of gender and tuberculosis in Bangladesh found that women had less 
access to public out-patient clinics than men (OR=0.86, 95%CI: 0.85-0.88) and that this 
lack  of  access  to  public  services  correlates  with  the  higher  use  of  private  service 
providers among women in some situations (Begum et al. 2001).  Given that accessing 
care from a private provider is causally linked to an increased risk of receipt of a non- 
standard regimen, this suggests that women may be more likely to receive a non-standard 




4.3 - Residence: 
 
Rural residence is associated with delays in accessing diagnosis and ongoing treatment 
for tuberculosis (Storla, Yimer, Bjune 2008). Research from a remote district in 
Southeastern Iran found that 67.1% of the tuberculosis cases were from rural villages, 
compared to 28.7% from urban areas (Khazaei 2005).  Tuberculosis is often associated 
with urban areas due to crowded living which increases transmission of the infection. 




feature of both rural and some urban areas of India.  Rural villages in this part of India 
generally have higher levels of poverty.   In Himachal Pradesh, 7.94% of the rural 
population lives below the poverty line, compared to 4.63% of the population in the 
urban areas (Planning Commission of  Himachal Pradesh, 2002?). A  study from the 
1960’s in Mysore District, India found that the prevalence of infection was 43.9% in 
semi-urban areas compared to 37.9% in rural villages (Narain et al., 1963).    While not 





4.3.1 - Residence and Type of Infection 
 
Residence has been associated with EPTB infection, with higher rates of EPTB found in 
semi-urban areas, however, this relationship is often confounded by HIV rates.  A study 
in Malawi found that there was a significantly higher incidence of TB, particularly new 
smear-negative and extrapulmonary cases in semi-urban townships, compared to rural 
areas (Banerjee, Harries, Salaniponi, 1999).  Higher rates of extrapulmonary TB are often 




4.3.2 – Residence and Category of Treatment 
 
Little literature has been found on associations between residence and category of 
treatment.   Category of treatment is directly related to accessing treatment over an 
extended period of time.  Individuals living in rural areas (villages) are less likely to be 
able to access ongoing treatment and to adhere to their regimen, indicating that they may 




study in Nepal found that treatment adherence (a predictor of category of treatment – 
non-adherence more likely to result in Cat. II/IV treatment) was associated with cost of 
travel to the TB treatment facility (versus no cost), which is likely to be greater for 
patients living in villages which are typically more remote (OR=3.0, 95%CI: 1.2-7.3) 
(Mishra et al., 2005).  Patients who default from treatment are more likely to be Category 
II/IV.  Research on default found that distance from home to treatment center was found 
to  be  positively  associated  with  risk  of  default  (HR=2.59,  p<0.001)  when  walking 
distance of more than two hours to the nearest treatment center was compared to walking 




4.3.3 - Residence and Treatment Regimen 
 
Using DOTS vs. non-DOTS as a proxy for treatment regimen (DOTS = standard 
regimen), the literature suggests that patients who are not on DOTS are more likely to 
live far from the health center (Naing et al. 2001).  This suggests that patients living in 





It is important to recognize that the distinction between village and town in the context of 
this study may be blurred and difficult to interpret.   A number of areas designated as 
villages are on the perimeter of towns, and thus are actually very close to treatment 





4.4  -  Hospital type in India 
 
Little data exists on the potential differences in risk of tuberculosis among patients 
seeking   treatment   at   public   vs.   private   providers   in   India,   particularly   when 
distinguishing mission/private hospitals from independent private practitioners.   The 
public system of care is supposed to be free of cost, reducing the socio-economic 
determinants of diagnosis and care.   However, in practice, government providers may 
demand  payment,  or  the  quality  of  care  may  be  considered  lower  than  at  private 
providers.  Less of a concern for risk of infection, but certainly a concern for treatment 
outcomes; some studies have found that private providers make more frequent errors in 
prescribing anti-tuberculosis treatment and are less likely to follow the standardized 
regimen developed by the government (Rao et al., 2000).  A greater use of the private 
health sector has been reported among women aged 15-24 in India (George et al. 1997 in 
RNTCP 2004).  While some policy analysts and medical providers view the private 
system  as  less  effective  in  some  cases  for  treating  tuberculosis  with  standardized 
regimens, many patients in India remain dissatisfied with the quality of treatment they 
receive  at  government  facilities,  with  the  stigma  they  may  face  from  government 
workers,  and  with  the  accessibility of  the  government healthcare providers.    Many 
believe the quality of care received at the private practitioners is better, not based on 





4.4.1 – Hospital and Type of TB 
 
At this time, no literature has been found on differences between public and 
mission/private hospitals and site of TB infection. It should be noted that extrapulmonary 
TB is more difficult to diagnose and often requires invasive procedures (including 
surgery) to obtain specimens for histopathological examination (Jawahar 2004).   The 
government hospital has very limited, if any, surgical facilities, and thus may be less 





4.4.2 – Hospital and Category of Treatment 
 
Category of treatment is based on the inclusion of second-line drugs.  Categories II and 
IV include one or more secondary drugs, whereas Categories I and III are made up of 
first-line drugs only.     Researchers in Gujarat, India found that public and private 
physicians differed significantly in their views of the effectiveness of second-line drugs. 
Private physicians were five times more likely to believe that second-line drugs were 
more effective than first line (Category I/III) drugs (37% compared to 7.1%) (Vyas, 
Small, & DeRiemer 2003).   This suggests that patients at the private hospital may be 





4.4.3 – Hospital and Treatment Regimen 
 
Hospital type is most likely to be associated with treatment regimen received, because 




through the RNTCP.   Literature has been found on private providers being less likely to 
provide  standardized  regimens  (Uplekar  &  Shepard  2004),  however,  this  is  not 
necessarily representative of the Mission hospital which used to participate as a DOTS 
center and is aware of the recommended standard regimen, whether they follow it or not. 
Also, the previous information presented on Indian private practitioners’ belief in the 
increased effectiveness of second-line drugs could also indicate that private practitioners 
are more likely to prescribe a non-standardized regimen because they augment the regular 




4.5 - Category of Treatment and Type of Treatment Regimen Received 
 
Little information was found on the possible association between category of treatment 
and receipt of a standard or non-standard regimen.   One review of the tuberculosis 
control program in Tajikistan did find that MDR (Category IV) patients often did not 
receive one of the standardized regimens recommended by the international guidelines 
under WHO (WHO Europe 2009).  This research also found that the patients who were 
most likely to not receive DOTS (standard) treatment were chronic or drug-resistant 
patients who would most likely be classified as Category II.  Therefore, one would expect 
that placement in the previously treated/complex (PTC – Cat. II/IV) would be associated 




While tuberculosis is generally a curable disease, it continues to exact an enormous toll 
on the country of India through lives lost and minimized productivity and the stress 




improved understanding of the groups of people most affected by TB in this region can 
help to target treatment programs, improve surveillance systems, and better understand 










1.   Study Design: 
 
The study is a retrospective review of medical records of all tuberculosis patients 
seen at the two hospitals in the town of Manali, District Kullu, Himachal Pradesh, India. 
The majority of the data was obtained at the initial diagnosis of disease, making it cross- 




2.  Description of the Participants and Criteria for Selection: 
 
Participants are all patients who visited the government or mission hospital and 
received a diagnosis of active tuberculosis disease between Jan 1, 2008 and Dec. 31, 
2011.   Patients under the age of 5 were excluded because of their different risk of 
infection and the variation in treatment.  Patients who tested positive for their purified 
protein derivative (PPD+)  only (latent infection) were also excluded, as they do not have 
active disease.   Individuals missing data on any of the six variables analyzed were 







Table 1:  Demographic Frequencies by Outcome of Site of TB Infection (N= 1086) 
  
Site of TB Infection 
 
Extrapulmonary, N(%) Pulmonary, N(%) 
 





Age (Categorical) N (%) N (%) 
<=25 135 (12.43%) 293 (26.98%) 
26-50 130 (11.97%) 341 (31.40%) 
>50 38 (3.50%) 149 (13.72%) 
Sex  
F 152 (14.00%) 299 (27.53%) 
M 151 (13.90%) 484 (44.57%) 
Residence  
Town 66 (6.08%) 121 (11.14%) 


















New, N(%)  Previously Treated/ 
Complex (PTC), N(%) 
 





Age (Categorical)  
<=25 337 (31.03%) 91 (8.38%) 
26-50 321 (29.56%) 150 (13.81%) 
>50 135 (12.43%) 52 (4.79%) 
Sex  
F 340 (31.31%) 111 (10.22%) 
M 453 (41.71%) 182 (16.76%) 
Residence  
Town 138 (12.71%) 49 (4.51%) 
Village 655 (60.31%) 244 (22.47%) 
  










Standard (S), N(%) Non-Standard (NS), N(%) 
 





Age (Categorical)  
<=25 353 (32.50%) 75 (6.91%) 
26-50 411 (37.85%) 60 (5.52%) 
>50 164 (15.10%) 23 (2.12%) 
Sex  
F 372 (34.25%) 79 (7.27%) 
M 556 (51.20%) 79 (7.27%) 
Residence  
Town 152 (14.00%) 35 (3.22%) 
Village 776 (71.45%) 123 (11.33%) 
  










LWH (Mission)  CIVIL (Government) 
Age (Mean, (SD)) 33.45 (16.40) 34.68 (16.39) 
Age (Categorical)  
<=25 142 (13.08%) 286 (26.34%) 
26-50 151 (13.90%) 320 (29.47%) 
>50 53 (4.88%) 134 (12.34%) 
Sex  
F 168 (15.47%) 283 (26.06%) 
M 178 (16.39%) 457 (42.08%) 
Residence  
Town 81 (7.46%) 106 (9.76%) 
Village 265 (24.40%) 634 (58.38%) 
TB Site  
EP 137 (12.62%) 166 (15.29%) 
P 209 (19.24%) 574 (52.85%) 
Treatment Category  
N 244 (22.47%) 549 (50.55%) 
PTC 102 (9.39%) 191 (17.59%) 
Regimen  
S 190 (17.50%) 738 (67.96%) 
NS 156 (14.36%) 2 (0.18%) 
  




3.  Data Collection: 
 
Data were collected from the Tuberculosis Registers (hand-written and excel files) 
maintained by each of the two hospitals in Manali for the years 2008-2011.  Tuberculosis 
patients are recorded into these registers at the time of diagnosis.  All information from 
the tuberculosis registers (medical records) were transcribed into an electronic format 
using Microsoft Excel.  Then the variables of age, gender, residence, treatment category, 
site of infection, and treatment regimen prescribed were abstracted and standardized for 




4.  Independent Variable Definition: 
 
Information was  collected from  medical records  on  the  following  independent 




4.1  -  Age: 
 
Age was collected as a continuous variable.  In some cases, for the purpose of analysis, 
the  variable  was  categorized  into  three  groups  (Var  =  Age_Cat3).    The  three  age 




4.2  -  Gender: 
 




4.3  -  Residence: 
 
Residence  information  was  collected  initially  based  on  village  name  recorded  for 
patient’s residence.  These names were then classified as either a village or town based 
upon the 2011 Census records for Himachal Pradesh. If the name was listed as one of the 
59 Census Towns in the State, it was assigned as a “Town”, otherwise, if not classified as 




A Census Town is defined by the 2011 Census of India as   “a village with minimum 
population of 5000; population density of at least 400 persons/sq km; and where >75% of 




4.4  - Hospital: 
 
Information on hospital was collected based on the hospital where the patient was 
registered and received tuberculosis treatment.  The two hospitals that were studied were 
the mission hospital: Lady Willingdon Hospital, and the government’s hospital: Civil 




4.5  -  Category of Treatment: 
 
Category of treatment was also used as an independent variable in one research question. 
Category of treatment was recorded in the medical records as one of fours categories – I, 






Table 5: Treatment Categories WHO  




New sputum smear-positive PTB 
New sputum smear-negative PTB, seriously ill 
New EPTB, seriously ill 
 
Category II 
Sputum smear-positive relapse 
Sputum smear-positive treatment failure 
Sputum smear-positive treatment after default 
 
Category III 
New sputum smear-negative, not seriously ill 
New EPTB, not seriously ill 
 
Category IV 
Suspect and Lab-Confirmed MDR (multi-drug 
resistant TB) 
 
Table 6: Treatment Categories Revised  




New (N) – (WHO Cat. I/III) 
New sputum smear-positive PTB 
New sputum smear-negative PTB, seriously ill 
New EPTB, seriously ill 
New sputum smear-negative, not seriously ill 
New EPTB, not seriously ill 
 
 
Previously Treated/Complex (PTC) – 
(WHO Cat. II/IV) 
Sputum smear-positive relapse 
Sputum smear-positive treatment failure 
Sputum smear-positive treatment after default 





Given changes to the categorization system, which now couples Categories I and III into 
a single Category I – and lack of accuracy in assigning patients into either Category II or 
IV because of uncertainty as to their resistance patterns, these four categories were then 
combined into two groups – N = newly treated patients (Cat. I and III), and PTC = 
Previously Treated or Complex patients (Cat. II and IV) (see Table: Categories Revised). 
Code 14 - Code 13 is a dosing for pediatric weight bands found occasionally in the data 
from  Civil  Hospital. These  cases  were  classified  as Category  I  if  not  otherwise 




5.  Dependent Variable Definition: 
 
Information was collected from  medical  records  on  the  following  dependent 




5.1 - TB Type: 
 
Site of Infection is listed in the medical records as either pulmonary or extrapulmonary. 
Definitions of site of infection are based on the 2003 WHO Tuberculosis Guideline 




“Pulmonary tuberculosis  (PTB)  refers  to  disease  involving  the  lung  parenchyma. 
 
Therefore tuberculous intrathoracic lymphadenopathy (mediastinal and/or hilar) or 
tuberculous pleural effusion, without radiographic abnormalities in the lungs, constitutes 
a case of extrapulmonary TB. A patient with both pulmonary and extrapulmonary TB 




Extrapulmonary tuberculosis (EPTB) refers to tuberculosis of organs other than the lungs, 
 
e.g. pleura, lymph nodes, abdomen, genitourinary tract, skin, joints and bones, meninges. 
Diagnosis should be based on one culture-positive specimen, or histological or strong 
clinical evidence consistent with active EPTB, followed by a decision by a clinician to 
treat with a full course of tuberculosis chemotherapy. The case definition of an 
extrapulmonary TB case with several sites affected depends on the site representing the 




In the event that a patient was diagnosed with both pulmonary and extrapulmonary forms 




5.2  -  Category of Treatment: 
 
Category of treatment was recorded in the medical records as one of fours categories – I, 
II, III or IV.  The definitions of these categories are as shown in the table and explanation 




5.3  -  Treatment Regimen: 
 
Treatment regimens were shown in different ways based upon the hospital where the 
patient was treated.  For the Civil Hospital, standard pre-formed treatment boxes are 
provided to the patients based upon their weight and category of treatment.  Thus, unless 
the patient from Civil Hospital was classified as NDI or NDII – standing for Non-DOTS 
Treatment, they were classified as having been given a standardized treatment regimen. 
The two patients who received ND II were classified as having received a non- 
standardized regimen. For the mission hospital, the drug names and dosages prescribed 
were recorded from the tuberculosis registers. These were then classified into standard or 
non-standard regimens, based upon the WHO tuberculosis treatment guidelines from 




Non-Standard if any of the following: 
 
a. Dose not contain HRZE for Cat. I/III (Isoniazid-INH, Rifampicin, 
Pyrazinamide, Ethambutol) 
b. Does not contain HRZES for Cat. II (Isoniazid-INH, Rifampicin, 
Pyrazinamide, Ethambutol, Streptomycin) 
c. Augmented with second-line drugs (ex. Amikacin, Ethinoamide, etc.) 
 
d. Dosage is less than minimum of range recommended by WHO 2003 (see 
tables 1 and 2 in appendix for reference) within 5kg weight bands 
e. For Suspect MDR (multi-drug resistant TB) – must not contain R or H.   If 
 
they received Ethionamide and Pyrazinamide + second line drugs, or a group 
of second-line drugs, then it was classified as Standard 
f. If no weight was recorded for the patient, the reasonability of the dosages 
were assessed based upon how the drugs are generally prescribed. If the doses 
were within reason, the regimen was classified as Standard. 
*Note:   Patients could be classified as MDR (or Suspect-MDR) and still receive a 
“standard” regimen, if they were identified as MDR and their regimen followed the 
























6.  Data Collection and Efforts to Reduce Bias 
 
Significant efforts were made to reduce the possibility of bias in the collection of 
data.  Data were obtained from handwritten TB registers of both the Civil and Mission 
Hospitals.  In some circumstances, partial information was missing from the register.  In 
these instances, the patients were contacted by telephone to verify details and to record 
any missing information.  This enabled details of all variables to be available for all but 
~50 records, out of more than 1000 patients.  Patient records from the registers were also 
reviewed with the outpatient/tuberculosis staff at the hospitals, to ensure inclusion in 
proper categories and to minimize any misclassification. 








Q1.   Are the people seen at the government hospital different than those seen at the 
private hospital with regard to the demographic characteristics of: age, gender, or 
residence in village/town? 
 
 
Descriptive analysis will be conducted by testing the differences between the observed 
and  hypothesized  proportions  of  each  of  the  independent  (age,  gender,  residence, 
hospital, category of treatment) and dependent variables (category of treatment, type of 
TB, and treatment regimen) using chi-squared analysis.  Initial chi-squared tests revealed 
a number of significant differences between the observed and hypothesized proportions 
(see Table 9 in Appendix). 
 
 
Q2.   Is there an association between the demographic characteristics (age, gender, 
residence, hospital), and site of TB infection (pulmonary, extrapulmonary-EPTB)? 
 
 
Analysis will begin with univariate analysis of the relationship between: 
 
●   The independent variable (age) and the dependent variable (site of TB infection); 
●   the independent variable (gender) and the dependent variable (site of TB infection); 
●   the  independent  variable  (residence)  and  the  dependent  variable  (site  of  TB 
infection); 
●   the independent variable (hospital) and the dependent variable (site of TB infection). 
 
 
Log (Odds) y = Intercept + B1X1 
 
Log (Odds) Site of Infection = B0 + B1 (age) 
Log (Odds) Site of Infection = B0 + B1 (gender) 
Log (Odds) Site of Infection = B0 + B1 (residence) 















Among the variables for which data is available, age and gender are expected to be 
potential confounders.  Previous research examining the outcome of site of infection 
considered gender and age to be confounders (Yang 2004). 
 
Effect Modifiers: 
Age and gender are hypothesized to be effect modifiers.  The association between age 
and the outcome of site of TB infection is expected to be different for men and women 
(gender).  This association is anticipated to differ when stratified by the third variable of 
gender.  Similarly, it is anticipated that the association between gender and site of 
infection may be different between different age groups.  Thus, interaction tests will be 
used to assess whether an interaction effect is present in this case.   Then stratified 
analysis can be conducted to compare the stratum specific odds ratios.  Research on site 
of infection of TB in Nepal found that the association between age and site of infection 
was different for men and women (Sreeramareddy 2008). 
 













Q3.  Is there an association between demographic characteristics and presenting with 
disease after treatment (DAT) – shown as classification in Category II/IV (PTC) as 
opposed to a first instance of TB shown by classification in Category I/III (N)? 
 
 
Analysis will begin with univariate analysis of the relationship between: 
●   The independent variable (age) and the dependent variable (Category of Treatment); 
●   the   independent  variable  (gender)  and   the   dependent  variable  (Category   of 
Treatment); 
●   the  independent  variable  (residence)  and  the  dependent  variable  (Category  of 
Treatment); 
●   the  independent  variable  (hospital)  and  the  dependent  variable  (Category  of 
Treatment). 
 
Log (Odds) y = Intercept + B1X1 
 
Log (Odds) Category of Treatment = B0 + B1 (age) Log 
(Odds) Category of Treatment = B0 + B1 (gender) Log 
(Odds) Category of Treatment = B0 + B1 (residence) Log 
(Odds) Category of Treatment = B0 + B1 (hospital) 
 
 




Log (Odds) y = Intercept + B1X1 + B2X2 + B3X3 + B4X4 
 






Age is a potential confounder for associations looking at outcomes of category of 
treatment.    Research  examining  gender  differences  in  TB  diagnosis  and  treatment 
adjusted for age in their presentation of odds ratios (Begum et al. 2001).  Therefore, one 
may need to consider age as a potential confounder of the relationship between TB 





It is hypothesized that there will be an interaction effect between age and gender. 
Interaction tests will be used to assess whether an interaction effect is present in this case. 




For example, the association between age and the outcome of category of treatment may 
be different for men and women (gender).  Thus interaction tests and crude odds ratios, 
stratified by gender will be examined to determine if effect modification is occurring. 
Similarly it is anticipated that the association between gender and category of treatment is 
different between different age groups.  Research from Bangladesh has shown differences 
in the male/female ratio observed for diagnosis, corresponding to category of treatment 








Analysis will begin with univariate analysis of the relationship between: 
●   The independent variable (age) and the dependent variable (Regimen); 
●   the independent variable (gender) and the dependent variable (Regimen); 
●   the independent variable (residence) and the dependent variable (Regimen); 
●   the independent variable (hospital) and the dependent variable (Regimen). 
 
 
Log (Odds) y = Intercept(B0) + B1X1 
 
Log (Odds) Regimen = B0 + B1 (age) Log 
(Odds) Regimen = B0 + B1 (gender) Log 
(Odds) Regimen = B0 + B1 (residence) Log 
(Odds) Regimen = B0 + B1 (hospital) 
 
 
Then, additional analysis of multivariate regression will be conducted to test for potential 
confounding, particularly by hospital type.   Hospital type is a potential confounder 
because it is causally associated with the outcome of interest of treatment regimen, due to 
the fact that the hospital type largely determines which treatment regimen is prescribed. 
It is also hypothesized to be associated with the exposures of age, gender and residence. 
No literature has been found to substantiate this hypothesis due to the unusual nature of 
the potential confounder and its specificity to this study, however, given the estimated 
strength of the association with the outcome of regimen and the suggested variability of 
the proportions of age, gender and residence between the two hospitals based on initial 
chi-squared analysis, it is reasonable to test for potential confounding. 
 
 
Log (Odds) y = Intercept + B1X1 + B2X2 + B3X3 + B4X4 
 
Log (Odds) Regimen = B0 + B1 (age) + B4 (hospital) Log 
(Odds) Regimen = B0 + B2 (gender) + B4 (hospital) Log 






I believe that there may also be several interaction effects and so therefore will consider 
effect modification in my final model between age and gender, age and hospital and 
gender and hospital. 
 
Log (Odds) Regimen = B0 + B1 (age) + B2 (gender) + (B1(age)*B2(gender)) 
Log (Odds) Regimen = B0 + B1 (age) + B4 (hospital) + (B1(age)*B4(hospital)) 




I hypothesize that the association between age and treatment regimen is different for men 
and women due to cultural attitudes related to both age and gender and sickness.  I also 
hypothesize that there will be an interaction effect between age and hospital where the 
association between age and treatment regimen is different for the two different hospitals, 
and similarly the association between gender and treatment regimen is different for the 







Q5.  Is there an association between category of treatment and type of treatment regimen 




Analysis will begin with univariate analysis of the relationship between: 
 
The independent variable (Category of Treatment) and the dependent variable (Regimen); 
 
 
Log (Odds) y = Intercept + B1X1 
 








Log (Odds) y = Intercept + B1X1 
 




I believe that there may also be an interaction effect and so therefore will consider effect 
modification in my final model between category of treatment and age, and between 
category of treatment and hospital type. 
 
Log (Odds) Regimen = B0 + B1 (Category of Treatment) + B2 (hospital) + (B1 (Category 
of Treatment)*B2 (hospital)) 
 
It is unclear at this time whether hospital type is more likely to act as a confounder or an 
effect modifier, and since this exposure has not been studied in the literature, it is not 
possible to classify it based upon previous research.  Thus, I propose to assess the 
interaction tests and crude odds ratios of the association between category of treatment 
and treatment regimen, stratified by hospital type, to determine whether hospital type is 









Research Q1. Are the people seen at the government hospital different than those seen 
at the private hospital with regard to the demographic characteristics of: age, gender, or 






Signficant differences were found between patients at the government and mission 
hospitals according to chi-squared tests in the areas of: 
• Age and Category of Treatment 
 
• Age and Type of TB Infection (P/EP) 
 
• Gender and Type of TB Infection 
 
• Gender and Treatment Regimen 
 
• Residence and Type of TB Infection 
 
• Hospital and Type of TB Infection 
 
• Hosptial and Treatment Regimen 
 
• Hospital and Gender 
 
• Hospital and Residence 
 





Therefore we must reject the null hypothesis which stated that no significant differences 




Research Q2.  Is there an association between the demographic characteristics (age, 
gender, residence, hospital), and site of TB infection (pulmonary, extrapulmonary- 
EPTB)? 
Null Hypothesis: There will be no association between the demographic 
 
characteristics (age, gender, residence, and/or hospital) and the site of tuberculosis 






Statistically significant associations were found between each of the independent 









Older patients (Age Cat. C: 50+years) are 45% less likely to develop EPTB as 
opposed Pulmonary TB, when compared to the reference age group (Cat. A: 0- 





Patients in the middle age category were also slightly less likely than the youngest 
patients to have EPTB, however, this association did not reach the level of 






Females are 1.63 times as likely to develop EPTB rather than pulmonary TB 
 







Patients who live in villages are 34% less likely to develop EPTB versus pulmonary 
 







Patients attending LWH were 2.27 times as likely to have EPTB versus pulmonary 
 





Thus, being younger, being female, living in a town, and being a patient at LWH were all 




Multivariate Adjusted Analysis (See Table 10): 
 
Age and Sex were tested as potential confounders, however, neither appear to be 
confounding any of the above relationships. Age and Sex were also evaluated as 




Therefore, we must reject the null hypothesis which states that there are no significant 













Table 10: Question 2 Odds Ratios  
 Outcome: TB Type (Extrapulmonary vs. Pulmonary) 
 Unadjusted Adjusted* 
Model Odds Ratio 95%CI Odds Ratio 95%CI 
Age (B - 25-50 y.o. vs. A – 0-25 y.o.) 0.83 0.62 - 1.10 0.86 0.64 -1.16 
Age (C – 50+ y.o. vs. A – 0-25 y.o.) 0.55 0.37 - 0.83 0.62 0.41 - 0.94 
Sex (Female vs. Male) 1.63 1.25 - 2.13 1.47 1.12 - 1.94 
Residence (Village vs. Town) 0.66 0.47 - 0.92 0.74 0.53 - 1.05 
Hospital (LWH vs. Civil) 2.27 1.72 - 2.99 2.12 1.60 - 2.81 




Research Q3. Is there an association between demographic characteristics and 
 
presenting with disease after treatment (DAT) – shown as classification in Category II/IV 




Null Hypothesis: There will be no association between the demographic 
 
characteristics (age, gender, residence, and/or hospital) and presenting with 
disease after treatment (DAT – Cat. I/III vs. Cat. II/IV), adjusting for potential 






A statistically significant association was found between Age and Category of Treatment 
 












Patients in the middle age category (Age Cat. B: 26-50 years) were 1.73 times as 
likely to be a PTC patient, rather than new, compared to the youngest group (Cat. A: 





Patients in the oldest age category (C: 50+ years) were 1.43 times as likely to be a 
PTC patient, rather than new, when compared to the youngest group age 0-25 years, 




Thus, being older was associated with an increased odds of having been previously 




Multivariate Adjusted Results (See Table 11): 
 
Age was assessed as a potential confounder in testing each of the associations 
between the demographic variables and the outcome of category of treatment, but 




Therefore, we must reject the null hypothesis which stated that there were no significant 
associations between the demographic variables and the outcome of disease after 
treatment/category of treatment. 
 
In the final model, with the inclusion of all independent variables, age was the only 
demographic variable which was significantly associated with the outcome of disease 






Table 11: Question 3 Odds Ratios  
 Outcome: Category of Treatment (PTC vs. New) 
 Unadjusted Adjusted* 
Model Odds Ratio 95%CI Odds Ratio 95%CI 
Age (B - 25-50 y.o. vs. A – 0-25 y.o.) 1.73 1.28 – 2.34 1.71 1.26 – 2.31 
Age (C – 50+ y.o. vs. A – 0-25 y.o.) 1.43 0.96 – 2.12 1.39 0.93 – 2.07 
Sex (Female vs. Male) 0.81 0.62 – 1.07 0.83 0.63 – 1.10 
Residence (Village vs. True) 1.05 0.73 – 1.50 1.06 0.74 – 1.53 
Hospital (LWH vs. Civil) 1.20 0.91 – 1.60 1.24 0.93 – 1.66 




Research Q4. Is there an association between demographic variables and type of 




Null Hypothesis: There will be no association between the demographic 
 
characteristics (age, gender, residence, and/or hospital) and type of treatment 
regimen received (standard vs. non-standard), adjusting for potential 









Age and sex were significantly associated with treatment regimen received. The 
association between residence and treatment regimen was marginally significant. 
Hospital type could not be included in the analysis because of the small number of Civil 











Patients in the middle age category (B: 26-50 years) are 31% less likely to receive a 
non-standard regimen, rather than the standard regimen compared to age category A 




Patients in the oldest age category (C: 50+ years) are 34% less likely to receive a non- 
standard regimen, rather than the standard regimen, compared to age category A (0- 







Females are 1.5 times as likely to receive a non-standard regimen, rather than the 






Patients from villages are 31% less likely to receive a non-standard regimen, rather 
than the standard regimen, when compared to patients from towns, and this 







Multivariate Adjusted Results (See Table 12): 
 
In the multivariate adjusted model including the variables of age, sex and 
residence, sex is the only variable which remains statistically significant. Age and 




According to the final adjusted model, females are 1.4 times as likely to receive a 




While it was not possible to calculate a stable odds ratio for the association 
between hospital type and regimen received, it is clear just from examining the 
frequencies of the treatment regimen type for each hospital that patients at LWH 
were substantially more likely to receive a non-standard regimen compared to 
their Civil Hospital counterparts. At LWH, 156 patients received a non-standard 
regimen, while 190 received the standard treatment. In contrast, at Civil Hospital 
only 2 patients received a non-standard regimen, while 738 patients received the 
standard WHO/DOTS treatment protocol. 
 
Therefore, we must reject the null hypothesis which stated that there was no significant 







Table 12: Question 4 Odds Ratios  
 Outcome: Treatment Regimen (Non-Standard vs. Standard) 
 Unadjusted Adjusted* 
Model Odds Ratio 95%CI Odds Ratio 95%CI 
Age (B - 25-50 y.o. vs. A – 0-25 y.o.) 0.69 0.48 – 0.99 0.71 0.49 – 1.03 
Age (C – 50+ y.o. vs. A – 0-25 y.o.) 0.66 0.40 – 1.09 0.72 0.43 – 1.20 
Sex (Female vs. Male) 1.50 1.07 – 2.10 1.44 1.02 – 2.02 
Residence (Village vs. Town) 0.69 0.46 – 1.04 0.70 0.46 – 1.06 




Research Q5. Is there an association between category of treatment and type of 





Null Hypothesis: There will be no association between category of treatment (N, 
 
PTC) and type of treatment regimen received (standard vs. non-standard), 














Univariate Results (See Table 13): 
 
An advanced treatment category (Disease after treatment/PTC) showed a 
marginally significant association with the outcome of treatment regimen as non- 




Multivariate Adjusted Results (See Table 13): 
 
Age, sex and residence were all tested as potential confounders and were 
determined to not be confounding the relationship between treatment category and 
regimen. Age was also assessed as a potential effect modifier with treatment 




included in this model because of the extremely small number of Civil Hospital 




A final model was tested with the inclusion of all variables (age, sex, residence, 
and treatment category). In the final model, all variables were significant (with 




• Treatment Category: 
 
Patients in the PTC treatment category were 1.5 times as likely to receive a non- 






Patients in the middle age category (Age Cat. B: 25-50 y.o.) were 32% less likely to 
receive a non-standard regimen, compared to patients in the young age category (Age 






Females were 1.46 times as likely to receive a non-standard regimen, compared to 






Residents of villages were 30% less likely to receive a non-standard regimen, 
compared to residents from towns, and this result was marginally significant 




Treatment category of PTC, middle age (25-50y.o.), and being female were 
significantly associated with an increased likelihood of receiving a non-standard 
regimen. 
 
Therefore, we must fail to reject the null hypothesis which stated that there would be no 





Table 13: Question 5 Odds Ratios  
 Outcome: Treatment Regimen (Non-Standard vs. Standard) 
 Unadjusted Adjusted* 
Model Odds Ratio 95%CI Odds Ratio 95%CI 
Treatment Category (PTC vs. New) 1.40 0.97 – 2.01 1.50 1.04 – 2.17 
Age (B - 25-50 y.o. vs. A – 0-25 y.o.) 0.69 0.48 – 0.99 0.68 0.47 – 0.99 
Age (C – 50+ y.o. vs. A – 0-25 y.o.) 0.66 0.40 – 1.09 0.70 0.42 – 1.17 
Sex (Female vs. Male) 1.50 1.07 – 2.10 1.46 1.03 – 2.06 
Residence (Village vs. Town) 0.69 0.46 – 1.04 0.70 0.46 – 1.06 








This study begins to fill an important gap in the literature on tuberculosis in India. 
Analysis of data showed significant differences in the relative distbribution of pulmonary 
and extrapulmonary tuberculosis between various demographic  sub-groups.  
Older patients were found to be more like to have been previously treated/complex.  
Patients attending the private hospital were more likely to receive a non-standard 
treatment regimen, while treatment at the government hospital adhered to a strict regimen 
with little possible alteration.  Finally, women, patients under age 25 and residents of 
towns were found to be more likely to receive a non-standard regimen.  These 
findings provide important insight into the distribution of disease in the population of 
District Kullu, as well as patterns of treatment.  The results can be used by the hospitals 
to target care and case-finding to the most at-risk populations, and to ensure the 
provision of the highest quality treatment to all individuals.  By highlighting areas  
where differences in associations have been found,  this research has highlighted the 
areas which require critical  analysis  to  determine if  the  differences are  the  result  of  




Significant differences were found between patients at the Civil and Mission 
Hospitals when analyzing the observed and expected proportions through chi-squared 
tests of a number of variables.  These findings indicate the need for additional analysis to 
determine the direction of the differences.   However, based on previous literature, 
differences were anticipated between the two hospitals, and between different 




women, while more men are infected with TB overall (SEARO/WHO 2009).  Also, 
treatment regimens are expected to vary between public and private providers in India 
(Vyas 2003).  These findings are consistent with the published literature on demographic 
distribution of site of infection, differences in treatment categories and regimens 
prescribed, and differences between public and private hospital’s treatment of TB 






Patients in the oldest age group (50+ y.o.) were the least likely to develop EPTB, 
while the patients in the youngest age category (0-25 y.o.) were the most likely. This is in 
line with the findings of other research on the distribution of EPTB by age (Yang et al. 
2004).  A study from Nepal which also found that age less than 25 years was significantly 
associated with EPTB, whereas older age was associated with a decreased probability of 
EPTB compared to PTB, found that a large number of cases of TB in the older age group 
appeared to be re-activation cases in the lungs (which would result in PTB) 
(Sreeramareddy et al. 2008).   They argue that “this may be due to decreased local 
immunity in the lungs in the elderly as a result of associated life-style factors (smoking) 
or co-morbid conditions which may predispose to re-activation in the lungs.”  They also 
cite a study from the UK which reported that co-mordid conditions, such as emphysema 
and bronchitis, which are typical among older patients, were independent risk factors for 
PTB (Jick et al., 2006).   However, it is also possible that the association between age and 




In this study, females were 1.63 times more likely to develop EPTB than males. 
The gender difference in site of infection is consistent with other studies which have 




The gender difference may be attributed to biological differences (e.g. genital 
tuberculosis in women), social differences in exposure (e.g. smoking), and/or differences 




Smoking is a major risk factor for pulmonary tuberculosis, and while highly 
prevalent among men (nearly 40% of adult men smoke in India), is not nearly as common 
amongst women (5% of adult women smoke) resulting in a higher likelihood of women 




A study from Peshawar, Pakistan found that women were 2 times as likely to 
develop EPTB as their male counterparts.  They too have found an explanation for this 
difference to be elusive, however do identify that the burden of EPTB was particularly 
high in women of reproductive age (15-45 y.o.) which points to the possible role of the 





Another  consideration  is  the  variation  in  exposure  to  other  risk  factors  for 
pulmonary TB which vary significantly between men and women.  Men are more likely 




increase the transmission of pulmonary TB from person to person.   Reactivation of a 
previously latent infection also impacts the site of tuberculosis.  A study by Musellim et 
al. (2005) found that reactivation of TB in the form of a pulmonary site occurred within 
the first five years in ~75% of the cases.  However, the infection reoccurred in the form 
of an extrapulmonary site within the first five years after contact in only 23.6% of the 
cases. Men may be exposed to more factors and co-morbid conditions which would 
result in them being more likely to have reactivation in a shorter period of time, in which 




Patients who live in villages rather than towns were 34% less likely to develop 
EPTB (more likely to present with PTB), meaning patients who lived in towns were more 




Little if any previous research has divided residence into towns and villages. 
Research that has compared residence of TB patients, typically looks at urban vs. rural. 
However, the state of Himachal Pradesh is extremely rural.  The only town that could by 
any reasonable standard be classified as urban in District Kullu is the district capital 
(Kullu).  Even classifying this as an urban center would be a stretch- it is best described 




A classification system of towns versus villages was chosen, because there are no 
urban areas, and because there are important differences between the towns and villages 




from that found in the towns.  Some villagers, particularly in the more remote villages, 
live in thatched houses.  Typically the homes are two stories with the cows and hay on 
the first level, and the people on the second. These homes are particularly sensitive to the 
harsh weather conditions of the region.  Also, many family members may live in close 
quarters.  Houses in the more rural villages are also more likely to use cooking stoves 
which produce significant amounts of smoke from the use of biomass cooking fuels, 
whereas individuals living in towns are more likely to have electric or kerosene stoves. 
The higher rates of PTB in the villages may be related to the use of indoor cooking fuels 
(wood/dung) which produce a lot of smoke.   Higher incidence of TB has been found 
among houses that use biomass cooking fuels in India (Mishra, 1999).   Logically, 
exposure to excess smoke from biomass cooking fuels should have a greater impact on 




LWH is a higher level care facility and thus is more likely to receive patients who 
are sicker or for whom it is less clear what illness they have (e.g. EPTB).  Also, EPTB is 
frequently determined by surgical biopsy and histopathological exam.  LWH has surgical 
facilities, whereas Civil Hospital does not, making it more likely for EPTB patients to be 




Patients in the middle age group were 1.73 times more likely to be PTC compared 




Patients in the oldest age group were 1.43 times more likely to be PTC compared to 
the youngest age group.  It is logical that patient’s who are previously treated/complex 
are likely to be older.  To fall into the previously treated category, the patient must have 
had active tuberculosis disease in the past for which they received treatment.  The 
likelihood of multiple instances of active disease will increase with age, as more time has 




Patients in the oldest category also had an elevated risk; however, this was 
somewhat less than the middle age group.  This may be the result of differences in the 




Patients in the middle age category (25-50 y.o.) were 31% less likely to receive a 
non-standard regimen then patients in the youngest age group.  The oldest patients were 
also less likely to receive a non-standard regimen then the youngest age group, but this 




Younger patients may have been most likely to receive a non-standard regimen 
because of the emotional toll on the prescribing physician of a very sick, young, patient, 
otherwise in the prime of their life.  A doctor who is confronted with a patient who is not 





In addition, it may be thought that a younger patient can better handle/cope with the 
side of effects of the second-line drugs, which tend to be more difficult to take.  Further, 
younger patients may be more willing to take injectables, which are the form that many 
of the second-line drugs take.   Younger patients are also less likely to have co- 
morbidities, or be taking drugs for other conditions which might interact with the less 




Females were 1.4 times more likely to receive a non-standard regimen compared to 
males. This finding is consistent with previous research which found that women were 
slightly more likely to receive a non-DOTS (non-standard regimen).  This was thought to 
be  primarily  due  to  the  increased  use  of  private  practitioners  by  women 




Another factor which may contribute to the higher use of non-standard treatment 
regimens in women may be the way in which they present with illness.   Many of the 
regimens were classified as non-standard because they were augmented with additional 
second-line  drugs,  often  after  the  patient  appeared  to  not  be  responding  to  initial 
treatment with a standard regimen.  Prescribing physicians may have viewed the female 
patients  as  more  frail,  and  thus  more  sick,  making  them  more  aggressive  in  their 
treatment strategy. Also, the fact that many of the female patients are mothers, who serve 
a critical role in providing and raising their children, may have encouraged the physicians 




This could also be the result of a tendency towards a nurturing behavior towards women, 




It is also possible that women were less likely to respond to their initial treatment 
(thus, leading the physician to augment the regimen) because they were less compliant 
with  taking  their  drugs  suffered  from  malnutrition, or  had  a  co-morbidity, such  as 
diabetes.   Women may have been more likely to put their family’s needs before their 
own,  including by  sacrificing the  maintenance of  an  appropriate treatment regimen. 
Many Indian women in this community also suffer from serious malnutrition.  Patients 
who are malnourished may be less responsive to treatment, thus increasing the likelihood 
of their regimen being augmented (Paul, 2012).  Diabetes mellitus is both a significant 
risk factor for tuberculosis and is known for making tuberculosis very difficult to treat. 
Patients with TB and diabetes often do not respond to the standard treatment regimen 
(Dooley and Chaisson 2009).   While diabetes is typically thought to occur more 
commonly in Indian men, it may be seriously under-diagnosed, particularly in women 
(Ramachandran 1993).  It is possible that more women are diabetic, and may not realize 
this, and thus fail to respond to the standard tuberculosis treatment, increasing the 




Patients from villages were 31% less likely to receive a non-standard regimen 
compared to patients who resided in a town.Patients from villages may have more trouble 
accessing the second-line, less frequently used drugs, which are often added to a regimen, 




standard regimen, because they were concerned about the patient’s ability to access the 
drugs on an ongoing basis.  Patients have to come to the hospital or village health worker 
for injectables (which is the form many of the second-line drugs take) and this is harder 





Previously Treated/Complex patients were more likely to receive a non-standard 
regimen that new patients. New patients receive a simple, drug cocktail that is generally 
not altered, unless the patient fails to respond or has unexpected side effects.  Thus, one 
would expect new patients to generally receive the standard regimen.  PTC patients 
require a more elaborate regimen that is subject to greater interpretation and in some 
cases, alteration by the physician.  Therefore, it makes sense that at least a marginal 




The results of this study provide significant insight into the distribution and factors 
associated with tuberculosis in District Kullu, India.  The data indicates that certain sub- 
populations (females, young ages, and residents of towns) are significantly more at risk 
of presenting with extrapulmonary infections, and thus this site of infection should be 
suspected when clinical symptoms are present.  This is particularly true among patients 
seen at the Mission Hospital.  However, it is also likely that extrapulmonary cases are 
being missed at the Civil Hospital due to the lack of surgical facilities.   Thus, the 




extrapulmonary cases from Civil to Mission Hospital may help to identify additional 




The results of this analysis also demonstrate that older patients (especially in the 
middle age group of 26-50 years) are significantly more likely to be patients who are 
previously treated/complex.  This finding is in line with anticipated outcomes, as older 
individuals would have had more opportunity to be treated in the past, however, it does 
indicate that physicians should recognize the increased likelihood of previous treatment 




The data from this retrospective review of medical records also reveals that 
particular sub-categories of patients are significantly more likely to be prescribed a non- 
standard regimen.  The issue of the superiority of standard versus non-standard regimens 
is not entirely straightforward.  Generally, the World Health Organization and other 
international bodies recommend that physicians prescribe a standard drug regimen for the 
treatment of TB patients; however, there are circumstances where an altered regimen may 
be more appropriate (e.g. managing side effects, not responding appropriately). 
However, it is best to limit the number of patients receiving non-standard treatments, as 
this is more likely to result in increased drug resistance.  Thus, it is important to 
determine which populations are receiving more non-standard treatments, and then to 
identify the reasons behind these treatment decisions.  Knowledge that females, residents 
of towns, and young patients (under age 25) receive more non-standard regimens at 




inform the physicians prescribing practices.   This may help to ensure that certain groups 












This study contained a number of important strengths.  First, the data was collected 
onsite in India by the researchers, with the full cooperation and collaboration of the 
participating hospitals.   The study was conducted at the request of the Medical 
Superintendent of the Mission Hospital, so it was both considered a priority, and the 
hospital staff were open to learning from the results of the analysis and making changes 
accordingly.  Because this consisted of primary data collection, it resulted in information 
that is not otherwise readily available or collected.  Also, being able to compare the 
government and mission hospital systems allowed for an additional depth to the analysis 
and  provides  useful  insights  which  may  be  applied  to  other  similar  scenarios. 
Importantly, the results of this study can be applied directly to the implementation of 
treatment by both hospitals.  Understanding the factors associated with different types of 
TB and treatments received can improve the quality of care provided, improve collection 
of surveillance date, target certain groups for outreach activities, and help to ensure that 
all sub-groups are receiving equal treatment.  Highlighting the issues of non-standard 
regimens can also provide the hospitals with an opportunity to re-evaluate their treatment 
practices and ensure they are in line with international guidelines, while tailoring to the 
specific needs of their patients.  An additional strength is the completeness of the 
variables which have been included for analysis.  The data from the two hospitals on the 
six variables described above is 95% complete and represents a significant sample size, 




systems are poorly maintained, this is a very small amount of missing data for these 
specific variables.  Through its collection of primary data, this study contributes to the 
body of literature on one of the major causes of morbidity and mortality in India, and 
addresses the epidemiology of the disease in a region where it has not been previously 









The study was not, however, without it’s limitations. The quality of the data was at 
times problematic.  Hand-written records were often difficult to read and frequently were 
missing important pieces of information. This may at times have affected the quality of 
the data (about 30% of the time).   However, efforts were made to enhance the data 
quality by review and confirmation with staff members who originally recorded the 
information.  For example, names of villages were checked with the staff to determine if 
they had been recorded correctly and were adjusted when errors were found.   Records 
often contained partial information as sections were not recorded in the register, largely 
due to the high volume of patients seen by the outpatient department of the hospital, thus 
the majority of analysis is limited to information that was collected at the first patient 
visit.   Treatment outcomes can not be studied because of missing data, and thus the 
ability to examine the data as a cohort over time is lost and it is reduced to a cross- 
sectional format .  This  data  would  also  have  allowed  for  the  study  of  possible 
associations between both demographic characteristics, treatment categories, regimens 




includes records from the government and mission hospitals. It does not include 
tuberculosis patients who were seen by other providers in the region including private 
practitioners and the District Hospital in Kullu.  The lack of information from these 
sources limits the generalizability of any findings. 
 
 
Also, the extremely low number of patients who received a non-standard regimen 
from the Civil Hospital meant that the hospital variable could not be included in some of 
the analysis.  It is possible that this variable is confounding the relationship between the 
demographic variables and treatment regimen.   It is also possible that other unknown 
confounders have been missed because of the lack of additional data and the fact that the 
patients were not randomized.  While every effort was made to reduce bias, it is possible 








Tuberculosis is one of the leading causes of morbidity and mortality in India.  It 
typically exerts its greatest toll on the young adult, most economically productive sector 
of society.  Better understanding of the distribution of the disease and factors associated 




Given the paucity of information available on tuberculosis in this region, this study 
helps fill the void of data which exists.   This information is needed to understand the 
epidemiologic situation and provide analysis of demographic variables, types of 
tuberculosis, and treatment factors.  This is particularly important because characteristics 
of tuberculosis infection within a population are known to vary considerably based on a 
wide variety of factors including geography and topography, access to care, and 
socioeconomic and cultural variables.  Thus, it is critical to examine tuberculosis within 
the context of a specific region.  Better understanding of the unique features of the 
distribution of tuberculosis among patients in this region, and the treatment mechanisms 
which are employed by the health systems will allow for improved diagnosis and 





Knowledge of the populations most at risk for tuberculosis and the way treatment 
differs based on these factors can also be used to affect the care patients receive.  For 
example, it is important to know if one gender is more likely to receive treatment at the 




more likely to receive a non-standard regimen.  This information can inform treatment 
practices and outreach services for detection of new cases. Finally, this data and analysis 










Tuberculosis remains one of the most prevalent and devastating infectious diseases 
in the world, exacting significant morbidity and mortality on it’s victims.  Identifying the 
populations most at risk for certain clinical presentations of TB, as well as the receipt of 
treatment can inform public health systems and improve the care provided to patients. 
This research determined that females, patients in the youngest age category (0-25 years), 
residents of towns, and patients seen at the Mission Hospital are significantly more likely 
to present with extrapulmonary TB.  This is critical knowledge, as EPTB can be difficult 
to diagnose.  Further, it was determined that older patients (especially those aged 26-50 
years) were significantly more likely to be in a more advanced category of 
treatment/disease after treatment.  In addition, females, residents of towns, and the 
youngest age group (0-25 years) were most likely to receive a non-standard treatment 
regimen.  Also, patients who were in the previously treated/complex category were 
significantly more likely to receive a non-standard regimen.  These findings raise 
important questions about the use of non-standard regimens and the practice of 
augmenting regimens with additional second-line drugs.  Together these results can help 
to target case finding efforts and to improve the quality of care and disease management 




This study provides the basis for many recommendations of areas for future study. 
More in-depth study is needed to better understand the differences in treatment regimen 




Greater insight into the gender differences in accessing care, as well as the difference in 
rates of extrapulmonary TB is also needed.  Better understanding of the roles of biologic 
versus social aspects of the disease and its treatment would enable the provision of more 
tailored care.  Also, improved study design (cohort study rather than cross-sectional) with 








1. Demonstrate the importance of epidemiology for informing scientific, ethical, 
economic, and political discussion of health issues. 
a. Measures of association found through epidemiologic techniques will be used 
to inform the scientific conduct of the medical professionals treating 
tuberculosis patients in this region. Information on the different application of 
treatment regimens may also inform important political, economic, and ethical 
discussions of equality of treatment access. 
2. Assess a public health problem in terms of magnitude, person, time and place. 
 
a. This research seeks to assess the burden of tuberculosis on the communities in 
 
District Kullu from 2008-2011. 
 
3. Distinguish among the basic terminology and definitions of epidemiology. 
 
a. The   research   conducted   distinguishes   between   statistically   significant 
association, marginally significant association, bias, causality, p-values, and 
95% confidence intervals. 
 
4. Discriminate key sources of data for epidemiological purposes. 
 
a. Key sources of data for this particular study include data from the World 
Health Organization, peer-reviewed scientific literature, and primary data 
collected in India. 
5. Calculate basic epidemiology measures. 
 
a. Measures of association, 95% Confidence intervals and p-values are being 
calculated. 
6. Evaluate the strengths and limitations of epidemiologic reports. 
 
a. Epidemiologic reports have been reviewed as part of the literature review and 
have been shown to include important information related to the variables 
associated with tuberculosis, as well as demonstrating the lack of information 
available with regard to this particular region. 




a. Measures of association are being used to draw appropriate inferences of 
association (not causation) between independent and dependent variables 
related to tuberculosis. 
8. Explain criteria for causality. 
 
a. This study will demonstrate the inability to determine causality because of its 
cross-sectional design. 
9. Calculate advanced epidemiology measures. 
 
a. Multiple logistic regression is being used to determine measures of association 
and significance. 
10.  Communicate epidemiologic information to lay and professional audiences. 
 
a. This data and report are being communicated to professional 
audiences through the thesis review.  In addition, the results of the study will 
be shared with the physicians and community in India that are affected. 
11.  Compare basic   ethical   and   legal   principles p e r t a i n i n g    to   the   
collection, maintenance, use, and dissemination of epidemiologic data and 
findings. 
a. Discussion may include the differing ethical and legal expectations regarding 
privacy and the collection, maintenance and dissemination of epidemiologic 
data, according to different regional contexts. 
b. The issue of data collection and use during investigation in a developing 
country was also addressed when approval was sought from the IRB. 
12.  Design, analyze, and evaluate an epidemiologic study. 
 
a. This research is an example of the design of a cross-sectional study through 
the review of medical records.  Possible associations will then be analyzed, 
and the research will be evaluated based on its merit and contribution to the 
scientific literature on the subject. 
13.  Demonstrate program administration and organizational leadership. 
 
a. The   research   demonstrates   program   administration   and   organizational 
leadership through the design of the study, collection of data from the 















































































Treatment Regimen 5.0482 0.0801 
 




















Treatment Regimen 3.1563 0.0756 






Variable Name  Categories Included 
Hospital  LWH (Mission) Hospital I Civil Hospital 
Age  A:0-25 I B:26-50 I C:>50 years 
Gender Male I Female 
Residence Town/Village 
Treatment Category New (N) I Previously Treated-Complex (PTC) 
TB Type/Site of infection Pulmonary (P) I Extrapulmonary (EP) 
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